None
Quote | Willow Biosciences (OTCMKTS:CANSD)
Last: | $ |
---|---|
Change Percent: | -3.04% |
Open: | $0.9381 |
Close: | $0.9381 |
High: | $0.9381 |
Low: | $0.9381 |
Volume: | 1,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Willow Biosciences (OTCMKTS:CANSD)
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share the company's plans to raise approximately $3 million. This capital will be used to support Willow Bioscience's recent partnership announcement with Laurus Labs. Dr. Savile explained that t...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share a significant development. The company has unveiled a noteworthy partnership with a Nasdaq-listed biopharmaceutical company, with a shared objective of forging precise and efficient manufacturi...
Message Board Posts | Willow Biosciences (OTCMKTS:CANSD)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share the company's plans to raise approximately $3 million. This capital will be used to support Willow Bioscience's recent partnership announcement with Laurus Labs. Dr. Savile explained that t...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share a significant development. The company has unveiled a noteworthy partnership with a Nasdaq-listed biopharmaceutical company, with a shared objective of forging precise and efficient manufacturi...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to announce a significant collaboration agreement between Willow Biosciences and Suanfarma. The partnership is focused on optimizing cell line productivity for manufacturing a high-volume anti-infec...